Strides Pharma Science Ltd. benchmarking: Performance to industry peers

Financial

	Strides Pharma Scien	Viyash Scientific	Procter&Gamble Healt
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	230.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	215.0 .	n/a	n/a
R&D as a % of Total Sales	1.84 %	0.0	n/a
Financials
5 yr Average ROE	30.1 %	4.43 %	36.03 %
5yr average Equity Multiplier	2.62	2.16	1.79
5yr Average Asset Turnover Ratio	0.6	0.95	0.77
5yr Avg Net Profit Margin	12.9 %	0.03 %	19.19 %
Price to Book	3.32	11.28	13.37
P/E	17.91	118.79	28.24
5yr Avg Cash Conversion Cycle	-51.45 Days	49.09 Days	-155.74 Days
Inventory Days	69.05 Days	80.25 Days	36.01 Days
Days Receivable	60.35 Days	79.76 Days	40.92 Days
Days Payable	225.58 Days	114.46 Days	215.28 Days
5yr Average Interest Coverage Ratio	0.72	1.93	500.05
5yr Avg ROCE	10.5 %	6.67 %	30.21 %
5yr Avg Operating Profit Margin	12.17 %	7.74 %	27.53 %
5 yr average Debt to Equity	1.01	0.53	0.0
5yr CAGR Net Profit	68.01 %	-25.52 %	4.02 %
5yr Average Return on Assets	10.97 %	0.05 %	15.5 %
Shareholdings
Promoter Holding	27.86 %	61.41 %	51.82 %
Share Pledged by Promoters	30.6 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.03 %	8.62 %	0.0
Change in Mutual Fund Holding (3 Yrs)	-3.06 %	5.57 %	3.2 %

Business

	Strides Pharma Scien	Viyash Scientific	Procter&Gamble Healt
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Active Pharmaceutical Ingredient 0 Formulations 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 42.77 Pharmaceutical 0 Formulations 56.23 Others 1.0	-
Location Wise Break-Up	Location Wise Break-Up North America 53.68 Europe 21.77 Africa 10.11 Australia 9.63 Asia Pacific 0.49 India 0.35 Turkey 0 LATAM 0 EM 0 Rest of the World 0 Asia 0 International 0 Domestic 0 Others 3.97	Location Wise Break-Up Asia Pacific 28.68 Africa 0 Turkey 0 Rest of the World 26.19 Europe 45.13 Asia Pacific 0 LATAM 0 India 0 International 0 EM 0 North America 0 Australia 0 Domestic 0	Location Wise Break-Up Asia 0 Africa 0 Turkey 0 Rest of the World 0 Europe 0 Asia Pacific 0 LATAM 0 India 0 International 6.81 EM 0 North America 0 Australia 0 Domestic 93.19
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical 100.0	-	-
Customer Segment	Customer Segment Regulated market 83.0 Emerging Market 11.0 Institutional Business 0 Less regulated market 0 Others 6.0	Customer Segment Regulated market 67.0 Less regulated market 33.0 Institutional Business 0 Emerging Market 0	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise India 43.68 Asia ex India 22.48 North America 18.17 Europe 10.2 Africa 5.48 Australia 0	-	-
Asset Break-Up	Asset Break-Up Pharmaceutical 97.35 Bio-Pharmaceutical 2.65 Rest of the World 0 Asia 0 Europe 0 India 0	Asset Break-Up Asia Pacific 43.23 Rest of the World 22.42 Europe 34.35 India 0 Pharmaceutical 0 Bio-Pharmaceutical 0	Asset Break-Up Asia 0 Rest of the World 0 Europe 0 India 100.0 Pharmaceutical 0 Bio-Pharmaceutical 0

Strides Pharma Science Ltd.

Strides Pharma Science Ltd.

Financial

Business

SIGN UP FOR FREE